Just one week after licensing its core high-content screening patent portfolio to GE Healthcare, Cellomics has struck another deal with the newly formed unit of GE.

This time, in a deal announced on June 29, Cellomics has agreed to collaborate with GE Healthcare to design and market an interface that allows images and data generated by GE Healthcare’s IN Cell Analyzer instruments to be mined, interpreted, and stored using Cellomics’ high-content informatics software platform. Financial terms of the deal were not disclosed.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The partially reinstated US travel ban leaves space for uncertainty for researchers, Nature News says.

Researchers find a number of traits differ by sex and could affect mouse model studies, according to Reuters.

Tweaking the skin microbiome could help address some skin conditions, the New York Times reports.

In PNAS this week: DNA methylation profiles of tumor tissue, gene dynamics in prokaryotes, and more.